vs

Side-by-side financial comparison of CHEGG, INC (CHGG) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $72.7M, roughly 1.7× CHEGG, INC). On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -49.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-15.5M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -35.4%).

Chegg, Inc., is an American educational technology company based in Santa Clara, California. It provides homework help, digital and physical textbook rentals, textbooks, online tutoring, and other student services, powered by artificial intelligence. The company has 6.6 million subscribers. Chegg has been widely criticized for facilitating cheating and academic dishonesty among students.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

CHGG vs CLB — Head-to-Head

Bigger by revenue
CLB
CLB
1.7× larger
CLB
$121.8M
$72.7M
CHGG
Growing faster (revenue YoY)
CLB
CLB
+47.9% gap
CLB
-1.4%
-49.4%
CHGG
More free cash flow
CLB
CLB
$16.0M more FCF
CLB
$517.0K
$-15.5M
CHGG
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-35.4%
CHGG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CHGG
CHGG
CLB
CLB
Revenue
$72.7M
$121.8M
Net Profit
$5.1M
Gross Margin
57.3%
Operating Margin
-47.2%
1.5%
Net Margin
4.2%
Revenue YoY
-49.4%
-1.4%
Net Profit YoY
EPS (diluted)
$-0.30
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHGG
CHGG
CLB
CLB
Q1 26
$121.8M
Q4 25
$72.7M
$138.3M
Q3 25
$77.7M
$134.5M
Q2 25
$105.1M
$130.2M
Q1 25
$121.4M
$123.6M
Q4 24
$143.5M
$129.2M
Q3 24
$136.6M
$134.4M
Q2 24
$163.1M
$130.6M
Net Profit
CHGG
CHGG
CLB
CLB
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$-17.5M
$14.2M
Q2 25
$-35.7M
$10.6M
Q1 25
$-17.5M
$-154.0K
Q4 24
$7.4M
Q3 24
$-212.6M
$11.7M
Q2 24
$-616.9M
$9.0M
Gross Margin
CHGG
CHGG
CLB
CLB
Q1 26
Q4 25
57.3%
20.8%
Q3 25
59.2%
22.0%
Q2 25
66.3%
20.3%
Q1 25
55.5%
19.5%
Q4 24
68.2%
17.8%
Q3 24
68.2%
20.5%
Q2 24
72.2%
21.2%
Operating Margin
CHGG
CHGG
CLB
CLB
Q1 26
1.5%
Q4 25
-47.2%
11.5%
Q3 25
-22.0%
15.6%
Q2 25
-34.7%
11.7%
Q1 25
-23.9%
3.6%
Q4 24
-19.0%
11.0%
Q3 24
-162.7%
14.7%
Q2 24
-297.3%
12.3%
Net Margin
CHGG
CHGG
CLB
CLB
Q1 26
4.2%
Q4 25
3.6%
Q3 25
-22.5%
10.6%
Q2 25
-33.9%
8.2%
Q1 25
-14.4%
-0.1%
Q4 24
5.7%
Q3 24
-155.7%
8.7%
Q2 24
-378.1%
6.9%
EPS (diluted)
CHGG
CHGG
CLB
CLB
Q1 26
$0.11
Q4 25
$-0.30
$0.11
Q3 25
$-0.16
$0.30
Q2 25
$-0.33
$0.22
Q1 25
$-0.17
$0.00
Q4 24
$-0.03
$0.15
Q3 24
$-2.05
$0.25
Q2 24
$-6.01
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHGG
CHGG
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$72.8M
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$119.6M
$275.1M
Total Assets
$278.0M
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHGG
CHGG
CLB
CLB
Q1 26
$22.8M
Q4 25
$72.8M
$22.7M
Q3 25
$96.4M
$25.6M
Q2 25
$85.6M
$31.2M
Q1 25
$88.3M
$22.1M
Q4 24
$315.7M
$19.2M
Q3 24
$361.1M
$21.5M
Q2 24
$345.5M
$17.7M
Total Debt
CHGG
CHGG
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CHGG
CHGG
CLB
CLB
Q1 26
$275.1M
Q4 25
$119.6M
$266.0M
Q3 25
$146.1M
$271.3M
Q2 25
$157.9M
$261.3M
Q1 25
$185.7M
$253.4M
Q4 24
$193.0M
$246.6M
Q3 24
$185.0M
$250.7M
Q2 24
$365.5M
$240.3M
Total Assets
CHGG
CHGG
CLB
CLB
Q1 26
$587.7M
Q4 25
$278.0M
$584.0M
Q3 25
$378.3M
$591.4M
Q2 25
$404.5M
$602.1M
Q1 25
$438.8M
$591.5M
Q4 24
$869.0M
$585.1M
Q3 24
$1.0B
$600.5M
Q2 24
$1.1B
$597.8M
Debt / Equity
CHGG
CHGG
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHGG
CHGG
CLB
CLB
Operating Cash FlowLast quarter
$-9.0M
$4.0M
Free Cash FlowOCF − Capex
$-15.5M
$517.0K
FCF MarginFCF / Revenue
-21.3%
0.4%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$-12.6M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHGG
CHGG
CLB
CLB
Q1 26
$4.0M
Q4 25
$-9.0M
$7.9M
Q3 25
$4.8M
$8.5M
Q2 25
$-4.8M
$13.9M
Q1 25
$24.5M
$6.7M
Q4 24
$18.1M
$20.6M
Q3 24
$39.5M
$13.1M
Q2 24
$14.2M
$17.1M
Free Cash Flow
CHGG
CHGG
CLB
CLB
Q1 26
$517.0K
Q4 25
$-15.5M
$5.0M
Q3 25
$-943.0K
$6.5M
Q2 25
$-12.1M
$10.4M
Q1 25
$15.9M
$3.9M
Q4 24
$4.8M
$17.4M
Q3 24
$23.7M
$10.4M
Q2 24
$-3.6M
$14.3M
FCF Margin
CHGG
CHGG
CLB
CLB
Q1 26
0.4%
Q4 25
-21.3%
3.6%
Q3 25
-1.2%
4.8%
Q2 25
-11.5%
8.0%
Q1 25
13.1%
3.1%
Q4 24
3.4%
13.4%
Q3 24
17.3%
7.7%
Q2 24
-2.2%
10.9%
Capex Intensity
CHGG
CHGG
CLB
CLB
Q1 26
Q4 25
8.9%
2.1%
Q3 25
7.4%
1.5%
Q2 25
6.9%
2.7%
Q1 25
7.1%
2.3%
Q4 24
9.3%
2.5%
Q3 24
11.6%
2.0%
Q2 24
10.9%
2.2%
Cash Conversion
CHGG
CHGG
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons